IRVINE, Calif., March 30, 2024 (GLOBE NEWSWIRE) — Concerning a launch issued below the identical headline on March 29, 2024 by AEON Biopharma, Inc. (NYSE: AEON; AEON.WS), please observe that…
Tag:
IRVINE, Calif., March 30, 2024 (GLOBE NEWSWIRE) — Concerning a launch issued below the identical headline on March 29, 2024 by AEON Biopharma, Inc. (NYSE: AEON; AEON.WS), please observe that…